Synthetic approaches to potent heterocyclic inhibitors of tuberculosis: A decade review

Department of Chemistry ,School of Advanced Sciences ,Vellore Institute of Technology ,Vellore ,India
Dasmahapatra, Upala;
Department of Chemistry ,School of Advanced Sciences ,Vellore Institute of Technology ,Vellore ,India
Chanda, Kaushik

Tuberculosis (TB) continues to be a significant global health concern with about 1.5 million deaths annually. Despite efforts to develop more efficient vaccines, reliable diagnostics, and chemotherapeutics, tuberculosis has become a concern to world health due to HIV, the rapid growth of bacteria that are resistant to treatment, and the recently introduced COVID-19 pandemic. As is well known, advances in synthetic organic chemistry have historically enabled the production of important life-saving medications that have had a tremendous impact on patients’ lives and health all over the world. Small-molecule research as a novel chemical entity for a specific disease target offers in-depth knowledge and potential therapeutic targets. In this viewpoint, we concentrated on the synthesis of a number of heterocycles reported in the previous decade and the screening of their inhibitory action against diverse strains of Mycobacterium tuberculosis . These findings offer specific details on the structure-based activity of several heterocyclic scaffolds backed by their in vitro tests as a promising class of antitubercular medicines, which will be further useful to build effective treatments to prevent this terrible illness.

Graphical Abstract


Citation style:
Could not load citation form.


License Holder: Copyright © 2022 Dasmahapatra and Chanda.

Use and reproduction: